Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 6 , Pages 620-627 , November 2009

Cancer and aging: The molecular pathways

References 

  1. American Cancer Society. Cancer Facts and Figures 2008. Atlanta: American Cancer Society; 2008;
  2. Tyner SD, Venkatachalam S, Choi J, et al. p53 mutant mice that display early aging-associated phenotypes. Nature. 2002;415:45–53
  3. Krtolica A, Parrinello S, Lockett S, et al. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proc Natl Acad Sci USA. 2001;98:12072–12077
  4. McMurray MA, Gottschling DE. An age-induced switch to a hyper-recombinational state. Science. 2003;301:1908–1911
  5. Finkel T, Holbrook NJ. Oxidants, oxidative stress, and the biology of aging. Nature. 2000;408:239–247
  6. Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298–300
  7. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev. 1998;78:547–581
  8. de Magalhaes JP, Church GM. Cells discover fire: Employing reactive oxygen species in development and consequences for aging. Exp Gerontol. 2006;41:1–10
  9. Orr WC, Sohal RS. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science. 1994;263:1128–1130
  10. Orr WC, Mockett RJ, Benes JJ, et al. Effects of overexpression of copper-zinc and manganese superoxide dismutases, catalase, and thioredoxin reductase genes on longevity in Drosophila melanogaster. J Biol Chem. 2003;278:26418–26422
  11. Parkes TL, Elia AJ, Dickinson D, et al. Extension of Drosophila lifespan by overexpression of human SOD1 in motor neurons. Nat Genet. 1998;19:171–174
  12. Hari R, Burde V, Arking R. Immunological confirmation of elevated levels of CuZn superoxide dismutase protein in an artificially selected long-lived strain of Drosophila melanogaster. Exp Gerontol. 1998;33:227–237
  13. Larsen PL. Aging and resistance to oxidative damage in Caenorhabditis elegans. Proc Natl Acad Sci USA. 1993;90:8905–8909
  14. Ruan H, Tang XD, Chen ML, et al. High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc Natl Acad Sci USA. 2002;99:2748–2753
  15. Moskovitz J, Bar-Noy S, Williams WM, et al. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci USA. 2001;98:12920–12925
  16. Yuan H, Kaneko T, Matsuo M. Relevance of oxidative stress to the limited replicative capacity of cultured human diploid cells: The limit of cumulative population doublings increases under low concentrations of oxygen and decreases in response to aminotriazole. Mech Aging Dev. 1995;81:159–168
  17. Benhar M, Engelberg D, Levitzki A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep. 2002;3:420–425
  18. Jackson AL, Loeb LA. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res. 2001;477:7–21
  19. Preston TJ, Muller WJ, Singh G. Scavenging of extracellular H2O2 by catalase inhibits the proliferation of HER-2/Neu-transformed rat-1 fibroblasts through the induction of a stress response. J Biol Chem. 2001;276:9558–9564
  20. Suh YA, Arnold RS, Lassegue B, et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature. 1999;401:79–82
  21. Irani K, Xia Y, Zweier JL, et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 1997;275:1649–1652
  22. Tsuzuki T, Egashira A, Igarashi H, et al. Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase. Proc Natl Acad Sci USA. 2001;98:11456–11461
  23. Polyak K, Waldman T, He TC, et al. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 1996;10:1945–1952
  24. Barja G. Endogenous oxidative stress: Relationship to aging, longevity and caloric restriction. Aging Res Rev. 2002;1:397–411
  25. Bayne AC, Mockett RJ, Orr WC, et al. Enhanced catabolism of mitochondrial superoxide/hydrogen peroxide and aging in transgenic Drosophila. Biochem J. 2005;391(Pt 2):277–284
  26. Miwa S, Riyahi K, Partridge L, et al. Lack of correlation between mitochondrial reactive oxygen species production and life span in Drosophila. Ann NY Acad Sci. 2004;1019:388–391
  27. Singh KK. Mitochondria damage checkpoint, aging, and cancer. Ann NY Acad Sci. 2006;1067:182–190
  28. Loeb LA, Wallace DC, Martin GM. The mitochondrial theory of aging and its relationship to reactive oxygen species damage and somatic mtDNA mutations. Proc Natl Acad Sci USA. 2005;102:18769–18770
  29. Ho YS, Magnenat JL, Bronson RT, et al. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem. 1997;272:16644–16651
  30. Schriner SE, Ogburn CE, Smith AC, et al. Levels of DNA damage are unaltered in mice overexpressing human catalase in nuclei. Free Radic Biol Med. 2000;29:664–673
  31. Huang TT, Carlson EJ, Gillespie AM, et al. Ubiquitous overexpression of CuZn superoxide dismutase does not extend life span in mice. J Gerontol A Biol Sci Med Sci. 2000;55:B5–B9
  32. Irmgard-Finger I. Science of cancer and aging. J Clin Oncol. 2007;25:1844–1851
  33. Blackburn EH. Structure and function of telomeres. Nature. 1991;350:569–573
  34. Huffman KE, Levene SD, Tesmer VM, et al. Telomere shortening is proportional to the size of the G-rich telomeric-3′-overhang. J Biol Chem. 2000;275:19719–19722
  35. Campisi J. Aging and cancer cell biology, 2008. Aging Cell. 2008;7:281–284
  36. von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann NY Acad Sci. 2000;908:99–110
  37. Harley CG, Vaziri HMCC, Allsopp RC. The telomere hypothesis of cellular aging. Exp Gerontol. 1992;27:375–382
  38. Joeng KS, Song EJ, Lee KJ, et al. Long lifespan in worms with long telomeric DNA. Nature Genetics. 2004;36:607–611
  39. Nakagawa S, Gemmell NJ, Burke T. Measuring vertebrate telomeres: Applications and limitations. Mol Ecol. 2004;13:2523–2533
  40. Optiz OG. Telomeres, telomerase, and malignant transformation. Curr Mol Med. 2005;5:219–226
  41. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells, which express telomerase activity. EMBO J. 1992;11:1921–1929
  42. Kujoth GC, Hiona A, Pugh TD, et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science. 2005;309:481–484
  43. Chondrogianni N, Stratford FL, Trougakos IP, et al. Central role of the proteasome in senescence and survival of human fibroblasts: Induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J Biol Chem. 2003;278:28026–28037
  44. Sitte N, Merker K, Von Zglinicki T, et al. Protein oxidation and degradation during cellular senescence of human BJ fibroblasts (Part I: Effects of proliferative senescence). FASEB J. 2000;14:2495–2502
  45. Hickman ES, Moroni MC, Helin K. The role of p53 and pRB in apoptosis and cancer. Curr Opin Genet Dev. 2002;12:60–66
  46. Feng Z, Hu W, Rajagopal G, et al. The tumor suppressor p53: Cancer and aging. Cell Cycle. 2008;7:842–847
  47. Lane MA, Ingram DK, Roth GS. The serious search for an anti-aging pill. Scientific Am. 2002;287:36–41
  48. Zhang Y, Herman B. Aging and apoptosis. Mech Aging Dev. 2002;123:245–260
  49. Spindler SR. Use of microarray biomarkers to identify longevity therapeutics. Aging Cell. 2006;5:39–50
  50. Holzenberger M. The role of insulin-like signaling in the regulation of aging. Horm Res. 2004;1(Suppl 62):89–92
  51. Levine AJ, Feng Z, Mak TW, et al. Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev. 2006;20:267–275
  52. Browner WS, Kahn AJ, Ziv E, et al. The genetics of human longevity. Am J Med. 2004;117:851–860
  53. Espejel S, Martin M, Klatt P, et al. Shorter telomeres, accelerated aging, and increased lymphoma in DNA-PKcs-deficient mice. EMBO Rep. 2004;5(5):503–509
  54. de Boer J, Andressoo JO, de Wit J, et al. Premature aging in mice deficient in DNA repair and transcription. Science. 2002;296:1276–1279
  55. Dolle ME, Busuttil RA, Garcia AM, et al. Increased genomic instability is not a prerequisite for shortened lifespan in DNA repair deficient mice. Mutation Res. 2006;596:22–35
  56. Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature. 2001;410:227–230
  57. Cohen HY, Miller C, Bitterman KJ, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004;305:390–392
  58. Futami K, Ishikawa Y, Goto M, et al. Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells. Cancer Sci. 2008;99:843–848
  59. Tollefsbol TO, Andrews LG. Mechanisms for methylation-mediated gene silencing and aging. Med Hypotheses. 1993;41:83–92
  60. Burzynski SR. Aging: Gene silencing or gene activation?. Med Hypotheses. 2005;64:201–208
  61. Baylin SB, Herman JG, Graff JR, et al. Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141–196
  62. Chen RZ, Pettersson U, Beard C, et al. DNA hypomethylation leads to elevated mutation rates. Nature. 1998;395:89–93
  63. Cahill DP, Lengauer C, Yu J, et al. Mutations of mitotic checkpoint genes in human cancers. Nature. 1998;392:300–303
  64. Shichiri M, Yoshinaga K, Hisatomi H, et al. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res. 2002;62:13–17
  65. Percy MJ, Myrie KA, Neeley CK, et al. Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes Chromosomes Cancer. 2000;29:356–362
  66. Wang X, Jin DY, Ng RW, et al. Significance of MAD2 expression to mitotic checkpoint controlling ovarian cancer cells. Cancer Res. 2002;62:1662–1668
  67. Baker DJ, Jeganathan KB, Malureanu L, et al. Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice. J Cell Biol. 2006;172:529–540
  68. Dai W, Wang X. Aging in check. Sci Aging Knowledge Environ. 2006;pe9
  69. Roobrouck VD, Ulloa-Montoya F, Verfaillie CM. Self-renewal and differentiation capacity of young and aged stem cells. Exp Cell Res. 2008;314:1937–1944
  70. Ho AD, Wagner W, Mahlknecht U. Stem cells and aging (The potential of stem cells to overcome age-related deteriorations of the body in regenerative medicine). EMBO reports. 2005;6:S35–S38
  71. Chen J, Astle CM, Harrison DE. Hematopoietic senescence is postponed and hematopoietic stem cell function is enhanced by dietary restriction. Exp Hematol. 2003;31:1097–1103
  72. Sharpless NE, DePinho RA. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol. 2007;8:703–713
  73. Weissman I. Stem cells: Unit of development, units of regeneration, and units of evolution. Cell. 2000;100:157–168
  74. Reya T, Clevers H. Wnt signaling in stem cells and cancer. Nature. 2005;434:843–850

PII: S1078-1439(09)00214-2

doi: 10.1016/j.urolonc.2009.07.013

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 6 , Pages 620-627 , November 2009

Article Tools